Evidence map›Paper›PMID 38577020›Full record

ArticleNon-coding RNA research2024

"Crosstalk between non-coding RNAs and transcription factor LRF in non-small cell lung cancer".

Magda Spella, Eleftherios Bochalis, Katerina Athanasopoulou, Argyri Chroni, Irene Dereki, Giannoula Ntaliarda, Ifigeneia Makariti, Georgios Psarias, Caterina Constantinou, Vasiliki Chondrou and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Non-coding RNA research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Magda SpellaBiology Laboratory, School of Science and Technology, Hellenic Open University, 26335 Patras, Greece.
Eleftherios BochalisBiology Laboratory, School of Science and Technology, Hellenic Open University, 26335 Patras, Greece.
Katerina AthanasopoulouBiology Laboratory, School of Science and Technology, Hellenic Open University, 26335 Patras, Greece.
Argyri ChroniBiology Laboratory, School of Science and Technology, Hellenic Open University, 26335 Patras, Greece.
Irene DerekiBiology Laboratory, School of Science and Technology, Hellenic Open University, 26335 Patras, Greece.
Giannoula NtaliardaDepartment of Physiology, Faculty of Medicine, University of Patras, Rio, 26504, Greece.
Ifigeneia MakaritiBiology Laboratory, School of Science and Technology, Hellenic Open University, 26335 Patras, Greece.
Georgios PsariasBiology Laboratory, School of Science and Technology, Hellenic Open University, 26335 Patras, Greece.
Caterina ConstantinouBiology Laboratory, School of Science and Technology, Hellenic Open University, 26335 Patras, Greece.
Vasiliki ChondrouBiology Laboratory, School of Science and Technology, Hellenic Open University, 26335 Patras, Greece.
Argyro SgourouBiology Laboratory, School of Science and Technology, Hellenic Open University, 26335 Patras, Greece.
Hellenic Open University · GRUniversity of Patras · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epigenetic approaches in direct correlation with assessment of critical genetic mutations in non-small cell lung cancer (NSCLC) are currently very intensive, as the epigenetic components underlying NSCLC development and progression have attained high recognition. In this level of research, established human NSCLC cell lines as well as experimental animals are widely used to detect novel biomarkers and pharmacological targets to treat NSCLC. The epigenetic background holds a great potential for the identification of epi-biomarkers for treatment response however, it is highly complex and requires precise definition as these phenomena are variable between NSCLC subtypes and systems origin. We engaged an in-depth characterization of non-coding (nc)RNAs prevalent in human

Indexed as

Epigenetic deregulationEpigenetic networksLong non-coding RNAsMicro-RNAsNon-small cell lung cancerTranscription factor LRF

Identifiers

PMID38577020
PMCPMC10990748
OpenAlexW4393120065

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.